Text Size

Long Term Follow-Up After Patients Underwent Total Hip Replacement

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
iri liebergall, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01687322
First received: August 23, 2012
Last updated: March 19, 2013
Last verified: March 2013
History of Changes
  Purpose

The investigators want to contact patients that underwent total hip replacement for the past ten years. The investigators will ask them about their daily living, functioning and quality of life.


Condition
Total Hip Replacement
Pain

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Hip Replacement
U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • quality of life [ Time Frame: up to ten years ] [ Designated as safety issue: No ]
    quality of life will be assessed by the SF-12 questionnaire. We will compare between the results from the last visit to the current.


Secondary Outcome Measures:
  • functioning [ Time Frame: up to ten years ] [ Designated as safety issue: No ]
    functioning will be assessed by the Harris Hip Score. We will compare between the results from the last visit to the current visit


Estimated Enrollment: 150
Study Start Date: January 2013
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
total hip replacement, quality of life, functioning

  Eligibility

Ages Eligible for Study:   28 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

men and women than underwent total hup replacment

Criteria

Inclusion Criteria:

1. total hip replacement from 01.01.2002

Exclusion Criteria:

1. no

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01687322

Locations
Israel
Hadassah Medical Organization
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: iri liebergall, Prof Meir (Iri) Liebergall, Chairman, Orthopedic Surgery Dept., Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01687322     History of Changes
Other Study ID Numbers: lieb004-CTIL-HMO
Study First Received: August 23, 2012
Last Updated: March 19, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
quality of life
functioning

ClinicalTrials.gov processed this record on May 23, 2013